Published by Josh White on 31st October 2022
(Sharecast News) - Immunotherapy developer Scancell announced on Monday that the first patient in the expansion phase of the monotherapy arms in the multicentre phase one clinical trial of 'Modi-1', dubbed 'ModiFY', had been enrolled and dosed.
URL: http://www.digitallook.com/dl/news/story/33073196/...